CircSLC7A6 promotes the progression of Wilms’ tumor via microRNA-107/ ABL proto-oncogene 2 axis

References

• Breslow NE, Beckwith JB, Perlman EJ, et al. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer. 2006;47(3):260–267.
   PubMed Web of Science ®Google Scholar
• Wang H, Shen Y, Sun N, et al. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms’ tumor. Chin Med J (Engl). 2012;125(10):1733–1739.
   PubMed Web of Science ®Google Scholar
• Szychot E, Apps J, Pritchard-Jones K. Wilms’ tumor: biology, diagnosis and treatment. Transl Pediatr. 2014;3(1):12–24.
   PubMedGoogle Scholar
• Hu Y, Yan J. Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children. Exp Ther Med. 2019;18(2):1021–1028.
   PubMed Web of Science ®Google Scholar
• Graf N, Van Tinteren H, Bergeron C, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012;48(17):3240–3248.
   PubMed Web of Science ®Google Scholar
• Green DM, Breslow NE, D’Angio GJ, et al. Outcome of patients with stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2014;61(1):134–139.
   PubMed Web of Science ®Google Scholar
• Guo JU, Agarwal V, Guo H, et al. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409.
   PubMed Web of Science ®Google Scholar
• Barrett SP, Wang PL, Salzman J. Circular RNA biogenesis can proceed through an exon-containing lariat precursor. Elife. 2015;4:e07540.
   PubMed Web of Science ®Google Scholar
• Liang H, Huang H, Li Y, et al. CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis. Biosci Rep. 2020;40(3). DOI:10.1042/BSR20193484
   Google Scholar
• Hu K, Qin X, Shao Y, et al. Circular RNA MTO1 suppresses tumorigenesis of gastric carcinoma by sponging miR-3200-5p and targeting PEBP1. Mol Cell Probes. 2020;52:101562.
   PubMed Web of Science ®Google Scholar
• Gu C, Lu H, Qian Z. Matrine reduces the secretion of exosomal circSLC7A6 from cancer-associated fibroblast to inhibit tumorigenesis of colorectal cancer by regulating CXCR5. Biochem Biophys Res Commun. 2020;527(3):638–645.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012;37(11):460–465.
   PubMed Web of Science ®Google Scholar
• Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–455.
   PubMed Web of Science ®Google Scholar
• Luo X, Dong J, He X, et al. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Biomed Pharmacother. 2020;125:109880.
   PubMed Web of Science ®Google Scholar
• Bao JW, Li WJ, Guo JH, et al. MiRNA-203a-5p alleviates the malignant progression of Wilms’ tumor via targeting JAG1. Eur Rev Med Pharmacol Sci. 2020;24(10):5329–5335.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu S, Xu Y, et al. Circular RNA-ZFR inhibited cell proliferation and promoted apoptosis in gastric cancer by sponging miR-130a/miR-107 and modulating PTEN. Cancer Res Treat. 2018;50(4):1396–1417.
   PubMed Web of Science ®Google Scholar
• Zhang X, Jin K, Luo JD, et al. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1. Neoplasma. 2019;66(5):704–716.
   PubMed Web of Science ®Google Scholar
• Song N, Ma X, Li H, et al. microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes. Urol Oncol. 2015;33(5):205. e201-211.
   PubMedGoogle Scholar
• Zhou Y, Zhang Z, Wo M, et al. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis. Bioengineered. 2021. DOI:10.1080/21655979.2021.1992330
   Google Scholar
• Feng J, Zhan J, Ma S. LRG1 promotes hypoxia-induced cardiomyocyte apoptosis and autophagy by regulating Hypoxia-inducible factor-1α. Bioengineered. 2021;12(1):8897–8907.
   PubMed Web of Science ®Google Scholar
• Gao Y, Tang Y, Sun Q, et al. Circular RNA FOXP1 relieves trophoblastic cell dysfunction in recurrent pregnancy loss via the miR-143-3p/S100A11 cascade. Bioengineered. 2021;12(1):9081-9093.
   Web of Science ®Google Scholar
• Yang B, Diao H, Wang P, et al. microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1. Bioengineered. 2021;12(1):9094-9102.
   Web of Science ®Google Scholar
• Zhang J, Cheng F, Rong G, et al. Circular RNA hsa_circ_0005567 overexpression promotes M2 type macrophage polarization through miR-492/SOCS2 axis to inhibit osteoarthritis progression. Bioengineered. 2021;12(1):8920–8930.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cheng H, Yue Y, et al. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells. Journal of Biomedical Science. 2018;25(1):11.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Dong X, Hu D, et al. Aquaporin 4 inhibition alleviates myocardial ischemia-reperfusion injury by restraining cardiomyocyte pyroptosis. Bioengineered. 2021;12(1):9021–9030.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Panda AC, Grammatikakis I, Kim KM, et al. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1. Nucleic Acids Res. 2017;45(7):4021–4035.
   PubMed Web of Science ®Google Scholar
• Gao S, Yu Y, Liu L, et al. Circular RNA hsa_circ_0007059 restrains proliferation and epithelial-mesenchymal transition in lung cancer cells via inhibiting microRNA-378. Life Sci. 2019;233:116692.
   PubMed Web of Science ®Google Scholar
• Zhang C, Xiong J, Yang Q, et al. Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells. Future Sci OA. 2018;4(9):FSOA340.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng F, Wang Z, et al. Circular RNA circ-SLC7A6 acts as a tumor suppressor in non-small cell lung cancer through abundantly sponging miR-21. Cell Cycle. 2020;19(17):2235–2246.
   PubMed Web of Science ®Google Scholar
• Greuber EK, Smith-Pearson P, Wang J, et al. Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer. 2013;13(8):559–571.
   PubMed Web of Science ®Google Scholar
• Hoj JP, Mayro B, Pendergast AM. A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis. Cell Rep. 2019;29(11):3421–3434. e3428.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shao C, Zhu L, et al. High expression of ABL2 suppresses apoptosis in gastric cancer. Dig Dis Sci. 2018;63(9):2294–2300.
   PubMed Web of Science ®Google Scholar
• Xing QT, Qu CM, Wang G. Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion. Onco Targets Ther. 2014;7:881–885.
   PubMed Web of Science ®Google Scholar
• Xu B, Wang C, Wang YL, et al. miR-143 inhibits renal cell carcinoma cells metastatic potential by suppressing ABL2. Kaohsiung J Med Sci. 2020;36(8):592–598.
   PubMed Web of Science ®Google Scholar
• Qin X, Wan Y, Wang S, et al. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2. Drug Des Devel Ther. 2016;10:71–79.
   PubMed Web of Science ®Google Scholar